IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q4 2017 Holdings

Filed 2018-02-14 | 6 holdings | $97.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Argos Therapeutics Inc.Common040221103$39.4K13,142,78440.5%
Protagonist Therapeutics, Inc.(PTGX)Common74366E102$20.4K982,27021.0%
Argos Therapeutics Inc.CallCommon040221103$15.4K5,120,60415.8%
Allena Pharmaceuticals(ALNAEUR)Common018119107$10.4K1,037,26710.7%
Jounce Therapeutics, Inc.(JNCEEUR)Common481116101$8.4K662,0638.7%
Proteon Therapeutics Inc.Common74371L109$3.2K1,667,9073.3%